Cargando…
Antioxidant and anti-inflammatory agents in chronic liver diseases: Molecular mechanisms and therapy
Chronic liver disease (CLD) is a continuous process that causes a reduction of liver function lasting more than six months. CLD includes alcoholic liver disease (ALD), non-alcoholic fatty liver disease (NAFLD), chronic viral infection, and autoimmune hepatitis, which can lead to liver fibrosis, cirr...
Autores principales: | Zhang, Chun-Ye, Liu, Shuai, Yang, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011909/ https://www.ncbi.nlm.nih.gov/pubmed/36926234 http://dx.doi.org/10.4254/wjh.v15.i2.180 |
Ejemplares similares
-
Pharmacological properties, molecular mechanisms and therapeutic potential of ginsenoside Rg3 as an antioxidant and anti-inflammatory agent
por: Wang, Jing, et al.
Publicado: (2022) -
Chronic Inflammatory Diseases, Anti-Inflammatory Agents and Their Delivery Nanosystems
por: Placha, Daniela, et al.
Publicado: (2021) -
Molecular Hydrogen: New Antioxidant and Anti-inflammatory Therapy for Rheumatoid Arthritis and Related Diseases
por: Ishibashi, Toru
Publicado: (2013) -
Antioxidant and Anti-Inflammatory Agents from the Sea: A Molecular Treasure for New Potential Drugs
por: Vasarri, Marzia, et al.
Publicado: (2022) -
Novel pyrrolopyrimidine derivatives: design, synthesis, molecular docking, molecular simulations and biological evaluations as antioxidant and anti-inflammatory agents
por: Sayed, Amira I., et al.
Publicado: (2022)